Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jan 1;84(1):106–112. doi: 10.1054/bjoc.2000.1555

Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

K J Bowman 1,2, D R Newell 1, A H Calvert 1, N J Curtin 1
PMCID: PMC2363607  PMID: 11139322

Abstract

The potent novel poly(ADP-ribose) polymerase (PARP) inhibitor, NU1025, enhances the cytotoxicity of DNA-methylating agents and ionizing radiation by inhibiting DNA repair. We report here an investigation of the role of PARP in the cellular responses to inhibitors of topoisomerase I and II using NU1025. The cytotoxicity of the topoisomerase I inhibitor, camptothecin, was increased 2.6-fold in L1210 cells by co-incubation with NU1025. Camptothecin-induced DNA strand breaks were also increased 2.5-fold by NU1025 and exposure to camptothecin-activated PARP. In contrast, NU1025 did not increase the DNA strand breakage or cytotoxicity caused by the topoisomerase II inhibitor etoposide. Exposure to etoposide did not activate PARP even at concentrations that caused significant levels of apoptosis. Taken together, these data suggest that potentiation of camptothecin cytotoxicity by NU1025 is a direct result of increased DNA strand breakage, and that activation of PARP by camptothecin-induced DNA damage contributes to its repair and consequently cell survival. However, in L1210 cells at least, it would appear that PARP is not involved in the cellular response to etoposide-mediated DNA damage. On the basis of these data, PARP inhibitors may be potentially useful in combination with topoisomerase I inhibitor anticancer chemotherapy. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: poly(ADP-ribose) polymerase, topoisomerase I, topoisomerase II, cytotoxicity, DNA damage

Full Text

The Full Text of this article is available as a PDF (97.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banasik M., Komura H., Shimoyama M., Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J Biol Chem. 1992 Jan 25;267(3):1569–1575. [PubMed] [Google Scholar]
  2. Barrows L. R., Holden J. A., Anderson M., D'Arpa P. The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replication. Mutat Res. 1998 Aug 7;408(2):103–110. doi: 10.1016/s0921-8777(98)00022-6. [DOI] [PubMed] [Google Scholar]
  3. Benjamin R. C., Gill D. M. Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J Biol Chem. 1980 Nov 10;255(21):10502–10508. [PubMed] [Google Scholar]
  4. Bernardi R., Negri C., Donzelli M., Guano F., Torti M., Prosperi E., Scovassi A. I. Activation of poly(ADP-ribose)polymerase in apoptotic human cells. Biochimie. 1995;77(5):378–384. doi: 10.1016/0300-9084(96)88150-8. [DOI] [PubMed] [Google Scholar]
  5. Bernges F., Zeller W. J. Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin. J Cancer Res Clin Oncol. 1996;122(11):665–670. doi: 10.1007/BF01209029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boulton S., Pemberton L. C., Porteous J. K., Curtin N. J., Griffin R. J., Golding B. T., Durkacz B. W. Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors. Br J Cancer. 1995 Oct;72(4):849–856. doi: 10.1038/bjc.1995.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bowman K. J., White A., Golding B. T., Griffin R. J., Curtin N. J. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br J Cancer. 1998 Nov;78(10):1269–1277. doi: 10.1038/bjc.1998.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Caldecott K. W., Aoufouchi S., Johnson P., Shall S. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res. 1996 Nov 15;24(22):4387–4394. doi: 10.1093/nar/24.22.4387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Caldecott K., Jeggo P. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutat Res. 1991 Sep;255(2):111–121. doi: 10.1016/0921-8777(91)90046-r. [DOI] [PubMed] [Google Scholar]
  10. Chatterjee S., Cheng M. F., Berger N. A. Hypersensitivity to clinically useful alkylating agents and radiation in poly(ADP-ribose) polymerase-deficient cell lines. Cancer Commun. 1990;2(12):401–407. doi: 10.3727/095535490820873958. [DOI] [PubMed] [Google Scholar]
  11. Chatterjee S., Cheng M. F., Berger S. J., Berger N. A. Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide. Cancer Res. 1994 Aug 15;54(16):4405–4411. [PubMed] [Google Scholar]
  12. Dantzer F., Schreiber V., Niedergang C., Trucco C., Flatter E., De La Rubia G., Oliver J., Rolli V., Ménissier-de Murcia J., de Murcia G. Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie. 1999 Jan-Feb;81(1-2):69–75. doi: 10.1016/s0300-9084(99)80040-6. [DOI] [PubMed] [Google Scholar]
  13. Darby M. K., Schmitt B., Jongstra-Bilen J., Vosberg H. P. Inhibition of calf thymus type II DNA topoisomerase by poly(ADP-ribosylation). EMBO J. 1985 Aug;4(8):2129–2134. doi: 10.1002/j.1460-2075.1985.tb03903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Daugherty J. P., Simpson T. A., Jr, Mullins D. W., Jr Effect of hyperthermia and doxorubicin on nucleoid sedimentation and poly (ADP-ribose) polymerase activity in L1210 cells. Cancer Chemother Pharmacol. 1988;21(3):229–232. doi: 10.1007/BF00262775. [DOI] [PubMed] [Google Scholar]
  15. Delaney C. A., Wang L. Z., Kyle S., White A. W., Calvert A. H., Curtin N. J., Durkacz B. W., Hostomsky Z., Newell D. R. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clin Cancer Res. 2000 Jul;6(7):2860–2867. [PubMed] [Google Scholar]
  16. Eriksson C., Busk L., Brittebo E. B. 3-Aminobenzamide: effects on cytochrome P450-dependent metabolism of chemicals and on the toxicity of dichlobenil in the olfactory mucosa. Toxicol Appl Pharmacol. 1996 Feb;136(2):324–331. doi: 10.1006/taap.1996.0039. [DOI] [PubMed] [Google Scholar]
  17. Ferro A. M., Olivera B. M. Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. J Biol Chem. 1984 Jan 10;259(1):547–554. [PubMed] [Google Scholar]
  18. Griffin R. J., Pemberton L. C., Rhodes D., Bleasdale C., Bowman K., Calvert A. H., Curtin N. J., Durkacz B. W., Newell D. R., Porteous J. K. Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP). Anticancer Drug Des. 1995 Sep;10(6):507–514. [PubMed] [Google Scholar]
  19. Halldorsson H., Gray D. A., Shall S. Poly (ADP-ribose) polymerase activity in nucleotide permeable cells. FEBS Lett. 1978 Jan 15;85(2):349–352. doi: 10.1016/0014-5793(78)80489-x. [DOI] [PubMed] [Google Scholar]
  20. Jeggo P. A., Caldecott K., Pidsley S., Banks G. R. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res. 1989 Dec 15;49(24 Pt 1):7057–7063. [PubMed] [Google Scholar]
  21. Kaufmann S. H. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta. 1998 Oct 1;1400(1-3):195–211. doi: 10.1016/s0167-4781(98)00136-5. [DOI] [PubMed] [Google Scholar]
  22. Kaufmann S. H., Charron M., Burke P. J., Karp J. E. Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo. Cancer Res. 1995 Mar 15;55(6):1255–1260. [PubMed] [Google Scholar]
  23. Kubota M., Tanizawa A., Hashimoto H., Shimizu T., Takimoto T., Kitoh T., Akiyama Y., Mikawa H. Cell type dependent activation of poly (ADP-ribose) synthesis following treatment with etoposide. Leuk Res. 1990;14(4):371–375. doi: 10.1016/0145-2126(90)90165-6. [DOI] [PubMed] [Google Scholar]
  24. Marks D. I., Fox R. M. DNA damage, poly (ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action. Biochem Pharmacol. 1991 Oct 24;42(10):1859–1867. doi: 10.1016/0006-2952(91)90582-p. [DOI] [PubMed] [Google Scholar]
  25. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998 Jun;18(6):3563–3571. doi: 10.1128/mcb.18.6.3563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mattern M. R., Mong S. M., Bartus H. F., Mirabelli C. K., Crooke S. T., Johnson R. K. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res. 1987 Apr 1;47(7):1793–1798. [PubMed] [Google Scholar]
  27. Milam K. M., Thomas G. H., Cleaver J. E. Disturbances in DNA precursor metabolism associated with exposure to an inhibitor of poly(ADP-ribose) synthetase. Exp Cell Res. 1986 Jul;165(1):260–268. doi: 10.1016/0014-4827(86)90550-1. [DOI] [PubMed] [Google Scholar]
  28. Moses K., Harris A. L., Durkacz B. W. Adenosine-diphosphoribosyltransferase inhibitors can protect against or potentiate the cytotoxicity of S-phase acting drugs. Biochem Pharmacol. 1988 Jun 1;37(11):2155–2160. doi: 10.1016/0006-2952(88)90575-8. [DOI] [PubMed] [Google Scholar]
  29. Moses K., Harris A. L., Durkacz B. W. Synergistic enhancement of 6-thioguanine cytotoxicity by ADP-ribosyltransferase inhibitors. Cancer Res. 1988 Oct 15;48(20):5650–5654. [PubMed] [Google Scholar]
  30. Moses K., Willmore E., Harris A. L., Durkacz B. W. Correlation of enhanced 6-mercaptopurine cytotoxicity with increased phosphoribosylpyrophosphate levels in Chinese hamster ovary cells treated with 3-aminobenzamide. Cancer Res. 1990 Apr 1;50(7):1992–1996. [PubMed] [Google Scholar]
  31. Negri C., Bernardi R., Braghetti A., Ricotti G. C., Scovassi A. I. The effect of the chemotherapeutic drug VP-16 on poly(ADP-ribosylation) in apoptotic HeLa cells. Carcinogenesis. 1993 Dec;14(12):2559–2564. doi: 10.1093/carcin/14.12.2559. [DOI] [PubMed] [Google Scholar]
  32. Pommier Y., Leteurtre F., Fesen M. R., Fujimori A., Bertrand R., Solary E., Kohlhagen G., Kohn K. W. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 1994;12(5):530–542. doi: 10.3109/07357909409021413. [DOI] [PubMed] [Google Scholar]
  33. Suto M. J., Turner W. R., Arundel-Suto C. M., Werbel L. M., Sebolt-Leopold J. S. Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. Anticancer Drug Des. 1991 May;6(2):107–117. [PubMed] [Google Scholar]
  34. Tanizawa A., Kubota M., Hashimoto H., Shimizu T., Takimoto T., Kitoh T., Akiyama Y., Mikawa H. VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase death. Exp Cell Res. 1989 Nov;185(1):237–246. doi: 10.1016/0014-4827(89)90052-9. [DOI] [PubMed] [Google Scholar]
  35. Yang S. W., Burgin A. B., Jr, Huizenga B. N., Robertson C. A., Yao K. C., Nash H. A. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11534–11539. doi: 10.1073/pnas.93.21.11534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zwelling L. A., Kerrigan D., Pommier Y., Michaels S., Steren A., Kohn K. W. Formation and resealing of intercalator-induced DNA strand breaks in permeabilized L1210 cells without the stimulated synthesis of poly(ADP-ribose). J Biol Chem. 1982 Aug 10;257(15):8957–8963. [PubMed] [Google Scholar]
  37. de Murcia G., Ménissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci. 1994 Apr;19(4):172–176. doi: 10.1016/0968-0004(94)90280-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES